His scientific interests lie mostly in Hemophagocytic lymphohistiocytosis, Immunology, Familial Hemophagocytic Lymphohistiocytosis, UNC13D and Pediatrics. His work carried out in the field of Hemophagocytic lymphohistiocytosis brings together such families of science as Gastroenterology, Reactive Hemophagocytic Syndrome, Hemophagocytosis and Macrophage activation syndrome. The study incorporates disciplines such as Cytotoxic T cell and Histiocytosis, Disease, Pathology in addition to Immunology.
In his work, Hepatosplenomegaly is strongly intertwined with Cytopenia, which is a subfield of UNC13D. The concepts of his Pediatrics study are interwoven with issues in Cancer, Hematopoietic stem cell transplantation, Hyponatremia, Treatment protocol and Rash. His research in the fields of Etoposide overlaps with other disciplines such as In patient.
Jan-Inge Henter focuses on Immunology, Hemophagocytic lymphohistiocytosis, Pediatrics, Internal medicine and Langerhans cell histiocytosis. In his study, Cancer research is inextricably linked to Cytotoxic T cell, which falls within the broad field of Immunology. His Hemophagocytic lymphohistiocytosis research is multidisciplinary, relying on both Hematopoietic stem cell transplantation, Transplantation, Etoposide, Macrophage activation syndrome and UNC13D.
As a part of the same scientific study, Jan-Inge Henter usually deals with the Pediatrics, concentrating on Disease and frequently concerns with Etiology. His biological study spans a wide range of topics, including Gastroenterology, Surgery and Oncology. Jan-Inge Henter has included themes like Langerhans cell, Histiocytosis and Interleukin 17 in his Langerhans cell histiocytosis study.
His primary scientific interests are in Immunology, Hemophagocytic lymphohistiocytosis, Langerhans cell histiocytosis, Internal medicine and Cancer research. The concepts of his Immunology study are interwoven with issues in Phenotype, Disease and Coronavirus disease 2019. His study in Hemophagocytic lymphohistiocytosis is interdisciplinary in nature, drawing from both Hematopoietic stem cell transplantation, Etoposide, Multiple organ dysfunction syndrome, Pediatrics and UNC13D.
The study incorporates disciplines such as Histiocyte and Familial Hemophagocytic Lymphohistiocytosis in addition to Etoposide. Jan-Inge Henter interconnects Salvage therapy and Dexamethasone in the investigation of issues within Familial Hemophagocytic Lymphohistiocytosis. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with issues in Sepsis.
Jan-Inge Henter spends much of his time researching Hemophagocytic lymphohistiocytosis, Immunology, Internal medicine, Immune system and Multiple organ dysfunction syndrome. His studies in Hemophagocytic lymphohistiocytosis integrate themes in fields like Histiocyte, Etoposide, Odds ratio and Late onset. His study looks at the relationship between Histiocyte and topics such as Pediatrics, which overlap with Cancer.
His Etoposide research is multidisciplinary, relying on both Salvage therapy, Intensive care medicine, Familial Hemophagocytic Lymphohistiocytosis and Dosing. His Immunology research is multidisciplinary, incorporating elements of Phenotype and Coronavirus disease 2019. His work on Cytarabine, Hematology and Gemcitabine as part of general Internal medicine study is frequently connected to SAMHD1, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.
Jan-Inge Henter;Annacarin Horne;Maurizio Aricó;R Maarten Egeler.
Pediatric Blood & Cancer (2007)
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Susan E. Stepp;Rémi Dufourcq-Lagelouse;Françoise Le Deist;Françoise Le Deist;Sadhna Bhawan.
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.
Jan-Inge Henter;Göran Elinder;Åke Öst.
Seminars in Oncology (1991)
Contemporary classification of histiocytic disorders
Blaise E. Favara;Alfred C. Feller;Macro Pauli;Elaine S. Jaffe.
Medical and Pediatric Oncology (1997)
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.
Jan-Inge Henter;AnnaCarin Samuelsson-Horne;Maurizio Aricò;R Maarten Egeler.
Hypercytokinemia in Familial Hemophagocytic Lymphohistiocytosis
Jan-Inge Henter;Göran Elinder;Olle Söder;Mona Hansson.
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
Takuya Sekine;André Perez-Potti;Olga Rivera-Ballesteros;Kristoffer Strålin.
Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11
Udo zur Stadt;Susanne Schmidt;Brigitte Kasper;Karin Beutel.
Human Molecular Genetics (2005)
INFECTION- AND MALIGNANCY-ASSOCIATED HEMOPHAGOCYTIC SYNDROMES Secondary Hemophagocytic Lymphohistiocytosis
Gritta Janka;Shinsaku Imashuku;Göran Elinder;Marion Schneider.
Hematology-oncology Clinics of North America (1998)
Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.
Aricò M;Janka G;Fischer A;Henter Ji.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: